RBPJ and ischemia: Compared with Rbpj conditional mutants with control injections, transfer of wild type monocytes improved the perfusion defects (Fig. 7g), arteriogenesis defect (Fig. 7h) and tissue damage (Fig. 7i) following ischemia, while transfer of Rbpj-deficient monocytes had no discernible effect.